224 related articles for article (PubMed ID: 8669389)
1. The menace of beta-lactamase production on antibiotic prescription in community acquired-infections in Nigeria.
Oyelese AO; Oyewo EA
Afr J Med Med Sci; 1995 Jun; 24(2):125-30. PubMed ID: 8669389
[TBL] [Abstract][Full Text] [Related]
2. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Lode H
Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactamase detection in nosocomial bacterial pathogens in Lagos, Nigeria.
Kesah CN; Odugbemi TO
Niger Postgrad Med J; 2002 Dec; 9(4):210-3. PubMed ID: 12690681
[TBL] [Abstract][Full Text] [Related]
4. Increasing prevalence of antimicrobial resistance among organisms isolated from blood culture in a Singapore hospital.
Kumarasinghe G; Chow C; Yin LH; Hong SY; Bassett DC
Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):116-22. PubMed ID: 7825001
[TBL] [Abstract][Full Text] [Related]
5. Approaches to reduce antibiotic resistance in the community.
Cohen R
Pediatr Infect Dis J; 2006 Oct; 25(10):977-80. PubMed ID: 17006310
[TBL] [Abstract][Full Text] [Related]
6. CTX-M-15 extended-spectrum (beta)-lactamase from Nigerian Klebsiella pneumoniae.
Soge OO; Queenan AM; Ojo KK; Adeniyi BA; Roberts MC
J Antimicrob Chemother; 2006 Jan; 57(1):24-30. PubMed ID: 16319181
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
9. Selection of antibiotic-resistant pathogens in the community.
Yagupsky P
Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
[TBL] [Abstract][Full Text] [Related]
10. Community-acquired respiratory infections: spectrum of organisms and treatment.
McKellar PP
J Med Liban; 2000; 48(4):264-9. PubMed ID: 11214199
[TBL] [Abstract][Full Text] [Related]
11. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.
Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A
J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569
[TBL] [Abstract][Full Text] [Related]
13. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
[TBL] [Abstract][Full Text] [Related]
14. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
[TBL] [Abstract][Full Text] [Related]
15. Antibiogram and beta-lactamase production of Staphylococcus aureus isolates from different human clinical specimens in Edo State, Nigeria.
Umolu PI; Okoli EN; Izomoh IM
West Afr J Med; 2002; 21(2):124-7. PubMed ID: 12403034
[TBL] [Abstract][Full Text] [Related]
16. Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription.
Potocki M; Goette J; Szucs TD; Nadal D
Infection; 2003 Dec; 31(6):398-403. PubMed ID: 14735382
[TBL] [Abstract][Full Text] [Related]
17. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of pathogens isolated from patients with community-acquired respiratory tract infections in Pakistan--the active study.
Zafar A; Hussain Z; Lomama E; Sibille S; Irfan S; Khan E
J Ayub Med Coll Abbottabad; 2008; 20(1):7-9. PubMed ID: 19024175
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
Doern GV
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358
[TBL] [Abstract][Full Text] [Related]
20. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
